Impact of Inflammation, Tumor and Product Attributes on Clinical Outcomes in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Axicabtagene CiloleucelSoumya Poddar, Sattva S. Neelapu, Gayatri Tiwari et al.|Blood|2024Cited by 0